NAT-TENOFOVIR
Identification of Nat-Tenofovir
| No description |
Google image searchProduct monograph
Active ingredient
tenofovir disoproxil fumarate, 300 MG
DIN: 02472511
Dosage form(s): TABLET
Route(s) of administration: ORAL
Schedule: Prescription
Company: NATCO PHARMA (CANADA) INC
Date: 15-MAR-2018
ATC:
- J05 — ANTIVIRALS FOR SYSTEMIC USE (ATC, ATC/DDD, )
- J05A — DIRECT ACTING ANTIVIRALS (ATC, ATC/DDD)
- J05AF — Nucleoside and nucleotide reverse transcriptase inhibitors (ATC, ATC/DDD)
- J05AF07 — TENOFOVIR DISOPROXIL (ATC/DDD)
Reference brand drug: Viread
Pharmaceutical standard: MFR
